House of Numbers, Full Documentary (The Aids Hoax) First let me start off by saying that Aids is a Hoax blog.myspace.com And its the drugs Global 2000 Report http://www.theforbiddenknowledge.com Aids symtoms vs the Aids drug side effects! The real Deal! Pt. 1 blog.myspace.com Aids symtoms vs the Aids drug side effects! The real Deal! Pt. 2 blog.myspace.com Are New Drug Treatments Responsible for Declines in AIDS? Government officials, AIDS organizations and the media unanimously agree that the recent decline in AIDS cases and deaths is an unprecedented occurrence due to a new combination of drugs that include protease inhibitors, chemicals said to block the replication of HIV. However, a careful look behind the headlines reveals that there is no medical evidence to support these popular claims about the protease inhibitor "combo cocktails. " The declines in AIDS deaths attributed to combination therapies actually began several years before protease inhibitor drugs became available for general use. (72) Since the first protease inhibitor received Food and Drug Administration (FDA) approval in December of 1995, a more likely explanation for decreased deaths would be the change in the official AIDS definition adopted in 1993 which allows HIV positives with no symptoms or illness … Continue reading →

In almost half of all cases, the drug interactions happened when ingredients in the supplements altered the way in which the prescribed drugs were absorbed and spread around the body, metabolised, and later removed from the system. A quarter of all the trends noticed were described as "major interactions", with the digestive and nervous systems most commonly affected. Dr Hsiang-Wen Lin, who led the study, said: "Consumer use of HDS has risen dramatically over the past two decades "Despite their widespread use, the potential risks associated with combining herbal and dietary supplements with other medications, which include mild-to-severe heart problems, chest pain, abdominal pain and headache, are poorly understood." In a linked editorial article Prof Edzard Ernst of the University of Exeter said: "Survey after survey shows that large proportions of the population are trying 'natural' remedies for illness-prevention, all sorts of ailments, diseases or for states of reduced well-being. "Most experts therefore agree that the potential for such interactions is substantial. "Despite this consensus and despite the considerable amount of documented harm generated by such interactions, our current knowledge is still woefully incomplete." Go here to read the rest: Herbal remedies linked to drug side effects … Continue reading →

Calls for companies to be made to publish the results of all its trials By Daniel Martin PUBLISHED: 19:48 EST, 23 October 2012 | UPDATED: 01:50 EST, 24 October 2012 Drug companies are deliberately withholding the results of adverse clinical trials - putting patients at risk, an MP warned yesterday. Dr Sarah Wollaston, a Tory backbencher, said pharmaceutical companies were burying bad news about the effectiveness and side effects of their medicines. She is backing a campaign for a change in the law to force drugs firms to publish the details of all trials - good or bad. Campaign: Calls are being made for a change to the law that would force drug companies to publish the results of all its trials The family doctor said such a move would save the NHS millions, because at the moment taxpayers fund medicines which may not be as effective as they claim. Yesterday Dr Wollaston told MPs: Missing data from clinical trials distorts the evidence and prevents patients and their doctors from making informed decisions about treatment. Here is the original post: Drug firms are 'risking lives by hiding bad trials and side effects of their medicines' … Continue reading →

LONDON Europe's top drug regulator announced Tuesday it is taking action against pharmaceutical giant Roche for allegedly failing to properly report the side effects of 19 drugs being used by U.S. patients. It is the first time the European Medicines Agency has begun a so-called 'infringement proceeding' against a drug maker. European regulations lay out numerous requirements for pharmaceuticals, including reporting suspected side effects and submitting such cases to officials. Eight of the drugs involved are used for the treatment of cancer, including breast cancer. They include Avastin, Herceptin, Tarceba, and Xeloda. The flu drug Tamiflu was also included in the list. British authorities brought the problem to the attention of the European authorities in May after noticing "serious shortcomings" in how Roche AG reported potential side effects. Regulators said about 80,000 reports by consumers of possible adverse effects to drugs sold in the U.S. had not been properly analyzed. Among those reports were over 15,000 deaths, though it was unclear if those deaths were caused by Roche medicines. The regulator said there was no evidence that users of Roche's drugs were at risk. The European Medicines Agency did not state what the side effects were but said it was … Continue reading →

A Bolton teen hanged himself from a tree four days after he started taking Cipralex, an antidepressant. His mother went online and filed a side-effect report to Health Canada. A pediatrician, troubled by the spate of side effects he was seeing in kids taking a generic version of an ADHD medication, faxed 25 reports to Health Canada over two months. After a 49-year-old York Region man killed himself while taking smoking-cessation drug Champix, his sister called in a side-effect report to Health Canada. All three say their reports were ignored. The Star has found Health Canada is not investigating individual reports of serious side effects. While the regulator periodically reviews the often-scant information in some reports, the Stars research shows it is not digging deeper to learn about troubling cases. We found no evidence that Health Canada, after receiving these reports, is doing any formal case investigations that would help the regulator better monitor drug safety. The mothers report went into cyberspace without a response. The sister received an impersonal form-letter thanking her for making the report about her dead brother. The doctor, who expected his faxed reports to alarm Health Canada and send its investigators digging for more information, … Continue reading →

Parker Waichman LLP is reporting that Tekturna, a drug used to treat hypertension, is associated with potentially fatal side effects. According to a report by the Institute for Safe Medication Practices (ISMP), the U.S. Food and Drug Administration (FDA) received at least 100 adverse event reports linked to the drug; among them were reports of angioedema, a rapid swelling that can lead to airway obstruction. New York, NY (PRWEB) October 31, 2012 The ISMPs QuarterWatch report, which is based on adverse event reports submitted to the U.S. Food and Drug Administration (FDA), found that the agency had received 100 reports of complications linked to Tekturna during the first quarter of 2012. The most serious and prominent side effect was angioedema, a medical condition that causes rapid swelling. Typically, the condition affects the face, tongue lips or throat; this can occur at any time during treatment and may be life threatening if the airway is obstructed, the ISMP states. The report also found that Tekturna might be harmful in at least some patient groups when taken with similar drugs that involve the renin-angiotensin system, including valsartan, sold under the brand name Diovan. In considering these safety issues, the ISMP questioned the … Continue reading →

LONDON (AP) - The European Medicines Agency has started an infringement procedure against pharmaceutical giant Roche for allegedly failing to properly report side effects in patients in the U.S. It is the first time the agency has begun such proceedings against a drug maker. European regulations lay out numerous requirements for pharmaceuticals, including reporting of suspected side effects and submitting such cases to officials. If Roche is found to have violated its reporting requirements, it could be fined up to five percent of its turnover in the European Union from the preceding year. Nineteen drugs are involved in the EU infringement procedure, including many for the treatment of cancer. There were more than 15,000 deaths among the reports of possible side effects, though it was unclear if those deaths were linked to Roche medicines. The European Commission, the executive body of the 27-country EU, asked the European Medicines Agency to instigate the infringement process. British authorities brought the problem to the attention of the European authorities in May after noticing "serious shortcomings" in how Roche AG reported potential side effects. Regulators said about 80,000 reports by consumers of possible adverse effects to drugs sold in the U.S. had not been … Continue reading →

LONDON (Reuters) - Europe's drug regulator has started an infringement procedure against Switzerland's Roche to investigate its alleged failure to properly report tens of thousands of potential drug side effects. If found guilty, the world's biggest maker of cancer medicines could be fined up to 5 percent of annual EU turnover which totaled 12.8 billion francs ($13.8 billion) in 2011, or 640 million francs. It was first time the London-based European Medicines Agency (EMA) has launched such proceedings since legislation came into force five years ago. "The agency will report the outcome of its investigation to the European Commission who may impose fines or periodic penalty payments ... if it finds that Roche has committed an infringement of its obligations," the EMA said on Tuesday. The issue of drug-safety reporting by Roche was first highlighted by the agency in June after a routine inspection by British investigators found it had failed to fully assess up to 80,000 cases of possible adverse drug reactions. There were some 15,000 deaths among the reports, which may have been due to natural disease progression but may have been connected to the drugs. That led to an immediate probe into public health implications. The latest … Continue reading →

LONDON (AP) Europe's top drug regulator announced Tuesday it is taking action against pharmaceutical giant Roche for allegedly failing to properly report the side effects of 19 drugs being used by U.S. patients. It is the first time the European Medicines Agency has begun a so-called 'infringement proceeding' against a drug maker. European regulations lay out numerous requirements for pharmaceuticals, including reporting suspected side effects and submitting such cases to officials. Eight of the drugs involved are used for the treatment of cancer, including breast cancer. They include Avastin, Herceptin, Tarceva, and Xeloda. The flu drug Tamiflu was also included in the list. British authorities brought the problem to the attention of the European authorities in May after noticing "serious shortcomings" in how Roche AG reported potential side effects. Regulators said about 80,000 reports by consumers of possible adverse effects to drugs sold in the U.S. had not been properly analyzed. Among those reports were over 15,000 deaths, though it was unclear if those deaths were caused by Roche medicines. The regulator said there was no evidence that users of Roche's drugs were at risk. The European Medicines Agency did not state what the side effects were but said it … Continue reading →